ribavirin has been researched along with Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, S; Ge, S; Nan, X; Tian, Y; Yang, R; Zhang, B; Zhang, Q; Zhu, S | 1 |
| Gharehbaghi, K; Grünberger, W; Jayaram, HN | 1 |
2 other study(ies) available for ribavirin and Sarcoma
| Article | Year |
|---|---|
Ribavirin inhibits cell proliferation and metastasis and prolongs survival in soft tissue sarcomas by downregulating both protein arginine methyltransferases 1 and 5.
Topics: Animals; Arginine; Cell Proliferation; Mice; Protein-Arginine N-Methyltransferases; Ribavirin; Sarcoma; Vascular Endothelial Growth Factor A | 2022 |
Studies on the mechanism of action of benzamide riboside: a novel inhibitor of IMP dehydrogenase.
Topics: Antineoplastic Agents; Cell Survival; Central Nervous System Neoplasms; Humans; IMP Dehydrogenase; Isoenzymes; Nucleosides; Organoselenium Compounds; Ribavirin; Ribonucleosides; Sarcoma; Tumor Cells, Cultured | 2002 |